HEALTH: Requests the Louisiana Department of Health to study the effects of gender affirming therapy on mental health
Read by title, under the rules, referred to the Committee on Health and Welfare.
Summary
The House adopted a resolution urging the Louisiana Department of Health to investigate whether medications used in gender‑affirming hormone therapy are linked to psychosis and other serious psychiatric conditions in individuals age 26 or younger. The study would review peer‑reviewed literature, adverse‑event reports, and involve consultations with a range of medical and mental‑health experts, with results due to the legislature by February 1, 2027. It focuses on minors, adolescents and young adults who receive these treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 290 changes status, plus AI-powered summaries and stage predictions.
Sign up free